AzTrials
AzTrials

Informal CaregiverAidant TLCNCT07558356

Evaluation of the Effectiveness of the "Aidant TLC" Program, Delivered in Person and Remotely, on the Well-being of Informal Caregivers

A study testing Psychoeducation in people with Informal Caregiver, run by Innovation Alzheimer at 2 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

As the population ages in France, more people need help with daily activities. Family members and other informal caregivers often provide this support, which can be physically and emotionally demanding and may affect their well-being. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Informal Caregiver
What is being tested?
Psychoeducation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
2 sitesFrance
Study dates
5 Feb 2026to Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Being an informal caregiver of an adult requiring assistance with activities of daily living
  • Providing at least 4 hours of care per week (broadly defined, including direct care as well as help with tasks such as medication management and bill payment)
  • French-speaking
  • Ability to travel (for the in-person intervention) to Nice or Biot (France)
  • Access to the internet at home or in an easily accessible location (for the remote intervention).

Who cannot join

  • Inability to provide informed consent.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Philippe Robert, Professor contact

+33 4 92034770

phil.robert15@orange.fr

France2 sites, 2 recruiting
  • Créapolis

    Biot

    Philippe Robert, +33 0497216930, contact@jlncreapolis.fr

    Recruiting
  • Institut Claude Pompidou

    Nice, 06100

    Valeria Manera, +33 0786541588, valeria.manera@univ-cotedazur.fr

    Recruiting

Other trials in France

About this study

Official title: Évaluation de l'efficacité du Programme " Aidant TLC " en présentiel et à Distance Sur le Bien-être Des Aidants Naturels

As the population ages in France, more people need help with daily activities. Family members and other informal caregivers often provide this support, which can be physically and emotionally demanding and may affect their well-being.

This study evaluates the "Aidant TLC (Thrive, Learn, Connect)" program, a support program designed to help caregivers better manage stress, emotions, and relationships. The program has been developed in the United States but has not yet been tested in France.

Read more

The goal of this study is to compare the effects of the program when delivered in two formats: online (remote) and in person. A third group of participants will not receive the program during the study period but will be offered it afterward.

A total of 75 caregivers will take part in the study. Participants will be randomly assigned to one of the three groups. The program consists of weekly group sessions over several weeks. Questionnaires will be used before and after the program to measure mood, stress, confidence, and overall well-being.

The results of this study will help determine whether this program is effective and whether it can be offered more widely to support caregivers, including those who may have difficulty accessing in-person services.

Read the detailed description

Population aging is associated with a growing number of individuals experiencing loss of autonomy. Informal caregivers, most often family members or close relatives, play a central role in supporting dependent individuals at home. However, caregiving responsibilities are associated with substantial physical and psychological burden, including stress, emotional distress, and reduced quality of life. Interventions targeting psychosocial skills have shown promise in improving caregiver well-being. Online programs may improve accessibility, although their effectiveness can vary depending on implementation and participant engagement.

The Aidant TLC (Thrive, Learn, Connect) program is a psychosocial and educational intervention designed to enhance emotional regulation, interpersonal skills, and stress management among caregivers. Although developed and evaluated in the United States, this program has not yet been tested in France.

The primary objective of this randomized controlled trial is to compare changes in depressive symptoms and self-efficacy among three groups: (1) participants receiving the TLC intervention remotely, (2) participants receiving the TLC intervention in person, and (3) a control group receiving no intervention. Secondary objectives are to compare changes in caregiver burden, anxiety, perceived benefits of caregiving, empathy, and apathy across the three groups, and to assess adherence to the intervention in remote versus in-person formats.

This study is a three-arm randomized controlled trial including 75 participants (25 per group). Eligible participants are adult informal caregivers (≥18 years) providing at least 4 hours of care per week to a dependent adult, able to understand French, and with access to transportation (in-person group) or internet (remote group).

After baseline assessment (V0), participants will be randomized to one of the three groups using a computerized system. The intervention consists of weekly 2-hour sessions over 6 weeks, delivered either remotely or in person. The control group will not receive the intervention during the study period but will be offered participation after study completion.

Primary outcomes include changes in depressive symptoms (Patient Health Questionnaire-9, PHQ-9) and self-efficacy (General Self-Efficacy Scale, GSE) from baseline to post-intervention (V1). Secondary outcomes include caregiver burden (Zarit Burden Interview-12), anxiety (GAD-7), perceived caregiving benefits (Caregiver Reaction Assessment), empathy (Basic Empathy Scale), and apathy (Apathy Motivation Index). Adherence will be assessed through session attendance, and acceptability will be evaluated via questionnaire in intervention groups.

Data will be analyzed using repeated-measures ANOVA with time (baseline, post-intervention) as a within-subject factor and group (remote, in-person, control) as a between-subject factor. Independent-samples t-tests will be used to compare adherence and acceptability between intervention groups.

The total study duration is 36 months, including 12 months for recruitment, 12 months for intervention delivery, and 12 months for data analysis and dissemination.

If effective, the Aidant TLC program could provide an accessible intervention to improve caregiver well-being, particularly for individuals with limited access to in-person support. No significant risks are anticipated.

Being tested
Psychoeducation
Keywords
Psychoeducational intervention, Informal caregiver, Online intervention, Group intervention, In-person intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PsychoeducationBehavioural

    The Aidant TLC program is a 6-session therapeutic education program designed to develop emotional, interpersonal, and stress management skills in informal caregivers. https://caregivertlc.org/

Study groups in NCT07558356
Study groupRoleWhat they receive
In-person groupExperimentalPsychoeducation group intervention delivered in-person
Receives: Behavioral: Psychoeducation
Online groupExperimentalPsychoeducational group intervention delivered online
Receives: Behavioral: Psychoeducation
Control groupNo interventionNo intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depressive symptoms

    Depressive symptoms assessed using the Patient Health Questionnaire (PHQ-9);

    Measured: Assessments will take place at enrollment (T1), within the two weeks prior to the start of the intervention, and at the end of the 6-week intervention period (T2), which will occur no later than 2 weeks after the end of the intervention.

  2. Self-efficacy

    General Self-Efficacy Scale (GSE)

    Measured: Assessments will take place at enrollment (T1), within the two weeks prior to the start of the intervention, and at the end of the 6-week intervention period (T2), which will occur no later than 2 weeks after the end of the intervention.

Secondary outcomes (5)
  1. Caregiver burden

    Zarit Burden Interview, short version; ZBI-12

    Measured: Assessments will take place at enrollment (T1), within the two weeks prior to the start of the intervention, and at the end of the 6-week intervention period (T2), which will occur no later than 2 weeks after the end of the intervention.

  2. Anxiety

    Generalized Anxiety Disorder; GAD-7

    Measured: Assessments will take place at enrollment (T1), within the two weeks prior to the start of the intervention, and at the end of the 6-week intervention period (T2), which will occur no later than 2 weeks after the end of the intervention.

  3. Perceived caregiving benefits

    Caregiver Reaction Assessment; CRA

    Measured: Assessments will take place at enrollment (T1), within the two weeks prior to the start of the intervention, and at the end of the 6-week intervention period (T2), which will occur no later than 2 weeks after the end of the intervention.

  4. Empathy

    Basic Empathy Scale; BES

    Measured: Assessments will take place at enrollment (T1), within the two weeks prior to the start of the intervention, and at the end of the 6-week intervention period (T2), which will occur no later than 2 weeks after the end of the intervention.

  5. Apathy

    French Apathy Motivation Index - f-AMI

    Measured: Assessments will take place at enrollment (T1), within the two weeks prior to the start of the intervention, and at the end of the 6-week intervention period (T2), which will occur no later than 2 weeks after the end of the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2026
  2. Study start5 Feb 2026
  3. Primary completionJun 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07558356
Sponsor's protocol ID
2025-A01079-40
Acronym
Aidant TLC
Status last verified
Apr 2026
First submitted
11 Apr 2026
Last updated
30 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Psychoeducation in people with Informal Caregiver, run by Innovation Alzheimer at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Philippe Robert, Professor (+33 4 92034770, phil.robert15@orange.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depressive symptoms (time frame: Assessments will take place at enrollment (T1), within the two weeks prior to the start of the intervention, and at the end of the 6-week intervention period (T2), which will occur no later than 2 weeks after the end of the intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in